Prof. Giorgi Pkhakadze, MD, MPH, PhD
UK Restricts Prostate Cancer Screening to High-Risk Men Only
UK health advisors restrict prostate cancer screening to men with dangerous genetic variants and family cancer histories. The targeted approach…
ICU Rooftop Gardens Show Promise for Critically Ill Patient Recovery
King's College Hospital creates world's first ICU rooftop garden where critically ill patients receive life support treatment outdoors. Research shows…
Prostate Cancer Affects One in Eight Men: Early Symptoms and Detection Guidelines
New data reveals one in eight men will develop prostate cancer, yet early symptoms often go unrecognized. Understanding warning signs…
Biotech Industry Faces Strategic Inflection Point Amid Cost Pressures and Innovation Demands
Veteran biotech executive Jeremy Levin discusses how the industry faces a critical juncture with $2.6 billion average drug development costs…
ECDC Convenes 80 European Experts to Strengthen Respiratory Virus Surveillance
ECDC brought together 80 respiratory virus experts from across Europe in Vienna to strengthen regional surveillance capabilities. The annual ERVI-Net…
Gut microbiome screening could predict Parkinson’s disease risk years before symptoms emerge
New research published in Nature Medicine reveals that gut microbiome analysis could identify Parkinson's disease risk years before symptoms appear.…
Genetic-Environmental Interactions Accelerate Brain Aging in Latin America
New research reveals how poverty and pollution accelerate brain aging by up to 15 years across Latin America, overriding genetic…
Brain Scans Reveal No Widespread Inflammation in Long COVID Patients, Challenging Previous Theories
New brain imaging study finds no widespread inflammation in long COVID patients, instead revealing heightened activity in mood and emotion…